These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 955052)

  • 21. Radiological contrast mediums. XIX. Urinary metabolites of iodoxanic acid in man.
    Pitrè D; Fumagalli L; Fonberg-Broczek M
    Farmaco Sci; 1971 Oct; 26(10):882-90. PubMed ID: 5157787
    [No Abstract]   [Full Text] [Related]  

  • 22. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum.
    Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL
    Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bilimiro (B 11.420) "Bracco"--a new hepatotropic contrast medium for oral cholecystography].
    Lazecki L
    Pol Przegl Radiol Med Nukl; 1973; 37(4):509-11. PubMed ID: 4754004
    [No Abstract]   [Full Text] [Related]  

  • 24. Radiopaque contrast media. XXIX - Metabolism studies with iodoxamic acid.
    Pitrè D; Felder E
    Farmaco Sci; 1974 Oct; 29(10):793-801. PubMed ID: 4435214
    [No Abstract]   [Full Text] [Related]  

  • 25. Iodophenyl derivatives of -methylalanine and isovaline as potential oral cholecystographic agents.
    Shtacher G; Dayagi S
    J Med Chem; 1972 Nov; 15(11):1174-7. PubMed ID: 4654668
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study with a closed sequential design between iopronic and iocetamic acid in oral cholecystocholangiography with radiograms in short and standard times. Laboratory evaluation of hepatic function (author's transl)].
    Lutman M; Morassut S; Bigai M; Galassi G; Galofaro G; Piazza P
    Radiol Med; 1980; 66(7-8):517-22. PubMed ID: 6452657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies of local anesthetics. XLVIII. Preliminary analytical evaluation of substance K 1902 (pentacaine)].
    Subert J; Blesová B; Benes L; Ambrovic P; Borovanský A
    Cesk Farm; 1975 Jan; 24(1):5-9. PubMed ID: 1139652
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical and chemical aspects of residual contrast media in the intestine during oral cholecystography with Trijobil and Falignost].
    Quasdorf M; Becker C; Quasdorf G; Becker HW
    Radiol Diagn (Berl); 1977; 18(1):19-28. PubMed ID: 866607
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biotransformation of iomeglamic acid (Falignost)].
    Bornschein I; Borchert HH; Pfeifer S
    Pharmazie; 1974; 29(10-11):730-1. PubMed ID: 4438422
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical trial of cholecystographic contrast media].
    Colagrande C; Priolo F; Parrella RE
    Radiol Med; 1970 Sep; 56(9):825-31. PubMed ID: 5210610
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholecystography with orabilex: a comparative study.
    REEVES RJ
    Am J Roentgenol Radium Ther Nucl Med; 1960 May; 83():843-6. PubMed ID: 14436939
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of iocetamic acid and sodium iopodate in cholecystography.
    Golberg B
    Radiol Clin (Basel); 1977; 46(1):42-9. PubMed ID: 136669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Iodoxanic acid, a new oral cholecystographic contrast medium: comparison with iodopanoic acid].
    Orlandini I
    Radiol Med; 1970 Sep; 56(9):832-5. PubMed ID: 5210611
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemical composition and names of some principal water-soluble and cholecystographic contrast media.
    Strain WH
    Invest Radiol; 1970; 5(6):498-502. PubMed ID: 5501852
    [No Abstract]   [Full Text] [Related]  

  • 35. [Double-blind study using a new biliary contrast medium].
    Müller M; Wirth W; Hugentobler R
    Schweiz Rundsch Med Prax; 1973 Dec; 62(49):1517-8. PubMed ID: 4752181
    [No Abstract]   [Full Text] [Related]  

  • 36. Scintigraphic cholecystography--the problem of contrast media selection and labelling.
    Spaventi S; Strohal P; Huljev D; Filjak K; Cvrtila D
    Nucl Med (Stuttg); 1972 Nov; 11(3):265-9. PubMed ID: 4648967
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent triiodinated contrast media for oral cholecystocholangiography].
    Sviridov NK; Popova ZP; Varfolomeeva VN
    Med Radiol (Mosk); 1985 Feb; 30(2):58-60. PubMed ID: 3155821
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical trial of bilopaque (tyropanoate sodium) oral cholecystography. Evaluation of time for the optimal and peak opacification of the gallbladder.
    Han SY; Witten DM
    Radiology; 1974 Sep; 112(3):529-30. PubMed ID: 4843280
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biotransformation of iomeglamic acid (Falignost)].
    Bornschein I; Schäffner J; Pfeifer S
    Pharmazie; 1975 Mar; 30(3):196. PubMed ID: 1153481
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary complications following bunamiodyl.
    GUNN JA
    JAMA; 1961 Mar; 175():911-2. PubMed ID: 13709779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.